JPMorgan raised the firm’s price target on Edwards Lifesciences (EW) to $90 from $85 and keeps a Neutral rating on the shares following the Q3 upside.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences price target raised to $83 from $81 at Baird
- Edwards Lifesciences price target raised to $100 from $90 at Mizuho
- Edwards Lifesciences price target raised to $95 from $90 at Piper Sandler
- Edwards Lifesciences price target raised to $96 from $95 at Citi
- Edwards Lifesciences price target raised to $99 from $95 at Barclays